JMP Securities downgraded Ocera Therapeutics (NASDAQ: OCRX) from Market Outperform to Market Perform.Analyst Liisa Bayko comments "Top-line results from OCRX’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE